T1	Participants 251 271	patients with cancer
T2	Participants 419 463	BTcP in opioid-tolerant patients with cancer
T3	Participants 580 652	opioid-tolerant male and female patients (aged > or =17 years) with BTcP
T4	Participants 681 706	36 centers across the USA
T5	Participants 1412 1424	131 patients
T6	Participants 2546 2582	opioid-tolerant patients with cancer
